Good results should see $5+ per share. Bad results will see a wipeout. Right now there has been absolutely nothing to indicate we will see anything but very good results. I'm guessing $6 per share once results are released, and a sale price a bit above that at the end of the year.
This is purely going off the announcements made by the company to date and the unmet need in the market for this drug.
Today's prices could seem like a distant memory in a few months' time. Of course, what happens between now and any result announcement is anyone's guess, as it relies purely on sentiment rather than evidence.
Good results should see $5+ per share. Bad results will see a...
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.59M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.5¢ | 14.5¢ | $78.75K | 518.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3340 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 97318 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| ATX (ASX) Chart |